Activated cGAS-STING signaling promotes malignancy in metabolic dysfunction-associated fatty liver disease via mitochondrial DNA and immune cell dysfunction

Figure 4 Hepatic stimulator of interferon genes expressions are associated with Wnt3a and vimentin-1 signaling during metabolic dysfunction-associated fatty liver disease progression. A: Stimulator of interferon genes (STING) (white) expressions in NC livers; B: STING expressions in hepatocellular carcinoma (HCC) tissues; C: Wnt3a (red) in HCC tissues; D: Merged vimentin-1 (green) with STING and Wnt3a signals in HCC tissues. STING: Stimulator of interferon genes; VIM-1: Vimentin-1; DAPI: 4’,6-Diamidino-2-phenylindole.